{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:34:35Z","timestamp":1792802075160,"version":"4.5.0"},"update-to":[{"DOI":"10.1371\/journal.pmed.1004655","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000}}],"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Task Force for Global Health","award":["INF-CDC-R2R; INF-CDC-PV3, INF-CDC-PV4"],"award-info":[{"award-number":["INF-CDC-R2R; INF-CDC-PV3, INF-CDC-PV4"]}],"id":[{"id":"https:\/\/ror.org\/03747hz63","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Task Force for Global Health","award":["INF-CDC-R2R; INF-CDC-PV3, INF-CDC-PV4"],"award-info":[{"award-number":["INF-CDC-R2R; INF-CDC-PV3, INF-CDC-PV4"]}],"id":[{"id":"https:\/\/ror.org\/03747hz63","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Task Force for Global Health","award":["INF-CDC-R2R; INF-CDC-PV3, INF-CDC-PV4"],"award-info":[{"award-number":["INF-CDC-R2R; INF-CDC-PV3, INF-CDC-PV4"]}],"id":[{"id":"https:\/\/ror.org\/03747hz63","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Task Force for Global Health","award":["INF-CDC-R2R; INF-CDC-PV3, INF-CDC-PV4"],"award-info":[{"award-number":["INF-CDC-R2R; INF-CDC-PV3, INF-CDC-PV4"]}],"id":[{"id":"https:\/\/ror.org\/03747hz63","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Task Force for Global Health","award":["INF-CDC-R2R; INF-CDC-PV3, INF-CDC-PV4"],"award-info":[{"award-number":["INF-CDC-R2R; INF-CDC-PV3, INF-CDC-PV4"]}],"id":[{"id":"https:\/\/ror.org\/03747hz63","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Partnership for Influenza Vaccine Introduction"},{"name":"Partnership for Influenza Vaccine Introduction"},{"name":"Partnership for Influenza Vaccine Introduction"},{"name":"Partnership for Influenza Vaccine Introduction"},{"name":"Partnership for Influenza Vaccine Introduction"},{"name":"Ready2Respond"},{"name":"Ready2Respond"},{"name":"Ready2Respond"},{"name":"Ready2Respond"},{"name":"Ready2Respond"},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["2305-IAI-PDR-Flu-Vac"],"award-info":[{"award-number":["2305-IAI-PDR-Flu-Vac"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["2305-IAI-PDR-Flu-Vac"],"award-info":[{"award-number":["2305-IAI-PDR-Flu-Vac"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["2305-IAI-PDR-Flu-Vac"],"award-info":[{"award-number":["2305-IAI-PDR-Flu-Vac"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["2305-IAI-PDR-Flu-Vac"],"award-info":[{"award-number":["2305-IAI-PDR-Flu-Vac"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["2305-IAI-PDR-Flu-Vac"],"award-info":[{"award-number":["2305-IAI-PDR-Flu-Vac"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007156","name":"Innovation and Technology Commission - Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007156","name":"Innovation and Technology Commission - Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018336","name":"National Institute for Health Research Health Protection Research Unit","doi-asserted-by":"publisher","award":["NIHR200908"],"award-info":[{"award-number":["NIHR200908"]}],"id":[{"id":"10.13039\/100018336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018336","name":"National Institute for Health Research Health Protection Research Unit","doi-asserted-by":"publisher","award":["NIHR200908"],"award-info":[{"award-number":["NIHR200908"]}],"id":[{"id":"10.13039\/100018336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018336","name":"National Institute for Health Research Health Protection Research Unit","doi-asserted-by":"publisher","award":["NIHR200908"],"award-info":[{"award-number":["NIHR200908"]}],"id":[{"id":"10.13039\/100018336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec010\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Next-generation influenza vaccines (NGIVs) are in development and have the potential to achieve substantial reductions in influenza burden, with resulting widespread health and economic benefits. The prices at which their market can be sustained and which vaccination strategies may maximise health impact and cost-effectiveness, particularly in low- and middle-income countries, are unknown, yet such an understanding could provide a valuable tool for vaccine development and investment decision-making at a national and global level. To address this evidence gap, we projected the health and economic impact of NGIVs in 186 countries and territories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec011\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>We inferred current influenza transmission parameters from World Health Organization (WHO) FluNet data in regions defined by their seasonal influenza timing and positivity, and projected 30 years of influenza epidemics, accounting for demographic changes. We considered vaccines including current seasonal vaccines, vaccines with increased efficacy, duration, and breadth of protection, and universal vaccines, defined in line with WHO Preferred Product Characteristics. We estimated cost-effectiveness of different vaccination scenarios using novel estimates of key health outcomes and costs. NGIVs have the potential to substantially reduce influenza burden: compared to no vaccination, vaccinating 50% of children aged under 18 annually prevented 1.3 (95% uncertainty range (UR): 1.2\u20131.5) billion infections using current vaccines, 2.6 (95% UR: 2.4\u20132.9) billion infections using vaccines with improved efficacy or breadth, and 3.0 (95% UR: 2.7\u20133.3) billion infections using universal vaccines. In many countries, NGIVs were cost-effective at higher prices than typically paid for existing seasonal vaccines. However, tiered prices may be necessary for improved vaccines to be cost-effective in lower income countries. This study is limited by the availability of accurate data on influenza incidence and influenza-associated health outcomes and costs. Furthermore, the model involves simplifying assumptions around vaccination coverage and administration, and does not account for societal costs or budget impact of NGIVs. How NGIVs will compare to the vaccine types considered in this model when developed is unknown. We conducted sensitivity analyses to investigate key model parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec012\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study highlights the considerable potential health and economic benefits of NGIVs, but also the variation in cost-effectiveness between high-income and low- and middle-income countries. This work provides a framework for long-term global cost-effectiveness evaluations, and the findings can inform a pathway to developing NGIVs and rolling them out globally.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pmed.1004655","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T13:48:07Z","timestamp":1751291287000},"page":"e1004655","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["The potential global health impact and cost-effectiveness of next-generation influenza vaccines: A modelling analysis"],"prefix":"10.1371","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0434-5863","authenticated-orcid":true,"given":"Lucy","family":"Goodfellow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0380-1503","authenticated-orcid":true,"given":"Simon R","family":"Procter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7341-5114","authenticated-orcid":true,"given":"Mihaly","family":"Koltai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9210-9657","authenticated-orcid":true,"given":"Naomi R.","family":"Waterlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2353-7981","authenticated-orcid":true,"given":"Johnny A. N.","family":"Filipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6895-6071","authenticated-orcid":true,"given":"Carlos K. H.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0362-6717","authenticated-orcid":true,"given":"Rosalind M.","family":"Eggo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Jit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"WHO Technical Advisory Group for the Full Value of Influenza Vaccines Assessment and project team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Next-generation influenza vaccine impact modelling contributors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"issue":"10127","key":"pmed.1004655.ref001","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"AD Iuliano","year":"2018","journal-title":"Lancet"},{"issue":"12","key":"pmed.1004655.ref002","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/JOM.0000000000001120","article-title":"Influenza and Workplace Productivity Loss in Working Adults","volume":"59","author":"JJ Van Wormer","year":"2017","journal-title":"J Occup Environ Med"},{"issue":"9","key":"pmed.1004655.ref003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202787","article-title":"Health care costs of influenza-related episodes in high income countries: A systematic review","volume":"13","author":"C Federici","year":"2018","journal-title":"PLoS One"},{"key":"pmed.1004655.ref004","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijid.2023.02.002","article-title":"The global region-specific epidemiologic characteristics of influenza: World Health Organization FluNet data from 1996 to 2021","volume":"129","author":"C Chen","year":"2023","journal-title":"Int J Infect Dis"},{"issue":"1","key":"pmed.1004655.ref005","article-title":"Influenza vaccines: Past, present, and future","volume":"32","author":"Y-H Kim","year":"2022","journal-title":"Rev Med Virol"},{"key":"pmed.1004655.ref006","author":"World Health Organization.","year":"2024"},{"issue":"5","key":"pmed.1004655.ref007","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/infdis\/jix632","article-title":"Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis, and Meta-regression of Test-Negative Design Case-Control Studies","volume":"217","author":"B Young","year":"2018","journal-title":"J Infect Dis"},{"issue":"10","key":"pmed.1004655.ref008","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1093\/cid\/ciz411","article-title":"Influenza Vaccine Effectiveness: Defining the H3N2 Problem","volume":"69","author":"EA Belongia","year":"2019","journal-title":"Clin Infect Dis"},{"key":"pmed.1004655.ref009","year":"21"},{"key":"pmed.1004655.ref010","year":"2017"},{"issue":"1","key":"pmed.1004655.ref011","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12916-023-02830-w","article-title":"Potential health and economic impact of paediatric vaccination using next-generation influenza vaccines in Kenya: a modelling study","volume":"21","author":"NR Waterlow","year":"2023","journal-title":"BMC Med"},{"issue":"41","key":"pmed.1004655.ref012","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1016\/j.vaccine.2023.08.031","article-title":"The potential cost-effectiveness of next generation influenza vaccines in England and Wales: A modelling analysis","volume":"41","author":"NR Waterlow","year":"2023","journal-title":"Vaccine"},{"issue":"11","key":"pmed.1004655.ref013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005838","article-title":"fluEvidenceSynthesis: An R package for evidence synthesis based analysis of epidemiological outbreaks","volume":"13","author":"E van Leeuwen","year":"2017","journal-title":"PLoS Comput Biol"},{"key":"pmed.1004655.ref014","author":"World Health Organization."},{"issue":"10","key":"pmed.1004655.ref015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001527","article-title":"Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study","volume":"10","author":"M Baguelin","year":"2013","journal-title":"PLoS Med"},{"key":"pmed.1004655.ref016","author":"F Hartig","year":"2023"},{"issue":"7","key":"pmed.1004655.ref017","article-title":"Projecting contact matrices in 177 geographical regions: An update and comparison with empirical data for the COVID-19 era","volume":"17","author":"Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group.","year":"2021","journal-title":"PLoS Comput Biol"},{"key":"pmed.1004655.ref018","doi-asserted-by":"crossref","first-page":"04003","DOI":"10.7189\/jogh.13.04003","article-title":"Global and national influenza-associated hospitalisation rates: Estimates for 40 countries and administrative regions","volume":"13","author":"J Paget","year":"2023","journal-title":"J Glob Health"},{"issue":"8","key":"pmed.1004655.ref019","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/cid\/cix468","article-title":"Influenza Vaccination Modifies Disease Severity Among Community-dwelling Adults Hospitalized With Influenza","volume":"65","author":"C Arriola","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"2","key":"pmed.1004655.ref020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1473-3099(22)00493-5","article-title":"Severity of influenza illness by seasonal influenza vaccination status among hospitalised patients in four South American countries, 2013-19: a surveillance-based cohort study","volume":"23","author":"AK Regan","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"pmed.1004655.ref021","volume-title":"WHO guide for standardization of economic evaluations of immunization programmes","author":"World Health Organization","year":"2019"},{"issue":"9","key":"pmed.1004655.ref022","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s40273-020-00930-6","article-title":"Producing Standardized Country-Level Immunization Delivery Unit Cost Estimates","volume":"38","author":"A Portnoy","year":"2020","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"pmed.1004655.ref023","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(23)00162-6","article-title":"Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures","volume":"11","author":"A Pichon-Riviere","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"4","key":"pmed.1004655.ref024","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3390\/vaccines8040629","article-title":"Vaccine Prices: A Systematic Review of Literature","volume":"8","author":"R Hussain","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"pmed.1004655.ref025","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.jval.2019.07.001","article-title":"Cost-Effectiveness Analysis for Influenza Vaccination Coverage and Timing in Tropical and Subtropical Climate Settings: A Modeling Study","volume":"22","author":"M Yue","year":"2019","journal-title":"Value Health"},{"key":"pmed.1004655.ref026","author":"Institute for Health Metrics and Evaluation IHME."}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1004655","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T20:56:33Z","timestamp":1753822593000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004655"}},"subtitle":[],"editor":[{"given":"Rebecca F.","family":"Grais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004655","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]}}}